const values = {

  'smpc-olumiant-2016': {
    'author': '',
    'title': 'Olumiant Summary of Product Characteristics.',
    'otherInfo': '2016.'
  },
  'gabay-2014': {
    'author': 'Gabay C, et al.',
    'title': 'Biological agents in monotherapy for treatment of rheumatoid arthritis.',
    'otherInfo': 'Swiss Med Wkly 2014: 144: w13950.'
  },
  'taylor-2015-ra-beam': {
    'author': 'Taylor PC, et al.',
    'title': 'Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study.',
    'otherInfo': '2015.'
  },
  'eular-2016-smolen': {
    'author': 'Smolen JS and Landewé R.',
    'title': 'EULAR recommendations for the management of rheumatoid arthritis.',
    'otherInfo': '2016 update.'
  },
  'shuai-2003': {
    'author': 'Shuai K and Liu B.',
    'title': 'Regulation of JAK-STAT Signalling in the Immune System.',
    'otherInfo': 'Nat Rev Immunol. 2003;3(11):900-11.'
  },
  'oshea-2012': {
    'author': 'O\'Shea JJ and Plenge R.',
    'title': 'JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease.',
    'otherInfo': 'Immunity 2012;36(4):542-50.'
  },
  'bari-infographic-2016': {
    'author': '',
    'title': 'Baricitinib Phase 3 Program infographic.',
    'otherInfo': 'Available at: http://origin-qps.onstreammedia.com/origin/multivu_archive/ENR/Lilly_v12_infographic.pdf. Accessed: October 2016.'
  },
  'dataonile-2016': {
    'author': '',
    'title': 'Data on file.',
    'otherInfo': 'Eli Lilly and Company, 2016.'
  },
  'keystone-2016': {
    'author': 'Keystone E, et al.',
    'title': 'Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy.',
    'otherInfo': 'Presented at EULAR 2016.'
  },
  'clinical-trials-2016': {
    'author': '',
    'title': 'Clinicaltrials.gov. Available at: http://clinicaltrials.gov (NCT01711359, NCT01710358, NCT01721057, NCT01721044, NCT01885078).',
    'otherInfo': 'Accessed: December 2016.'
  },
  'dougados-2016': {
    'author': 'Dougados M, et al.',
    'title': 'Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs:results from the RA-BUILD study.',
    'otherInfo': 'Ann Rheum Dis. 2016;0:1–8.'
  },
  'genovese-2016': {
    'author': 'Genovese MC, et al.',
    'title': 'Baricitinib in Patients with Refractory Rheumatoid Arthritis.',
    'otherInfo': 'N Engl J Med. 2016;374:1243–52.'
  }

};

export default values;